Cyagen US
Latest round
- Series B
Last raised
- Feb 2020
Total raised
- $41M
Investors
- 5
About Cyagen US
Cyagen US Inc.Founded in 2005, Cyagen US Inc. is headquartered in Santa Clara, US. The company focuses on providing preclinical research solutions and has undergone significant growth since its establishment.Cyagen Biosciences specializes in advanced preclinical research solutions, offering a comprehensive suite of products and services focused on genetic engineering and model development. Their core offerings include genetically engineered animals, custom cell lines, and virus packaging solutions tailored for research in therapeutic areas such as oncology, ophthalmology, and neuroscience. Cyagen provides essential models that replicate human diseases, enabling efficient drug discovery and development. Their flagship products include the HUGO-GT™ humanization models and various knockout and knockin models designed to meet the precise needs of biomedical researchers.Cyagen Biosciences generates revenue through a structured transaction model encompassing both custom services and product sales. Clients typically engage with the company for preclinical research projects, resulting in contracts that may include the development of custom genetically engineered animals or cell lines, as well as virus packaging services. The company offers tiered pricing structures tailored to specific projects, including a 50% discount on initial iPSC editing projects for new clients. Partnerships and collaborations with global bioscience organizations further enhance Cyagen's revenue streams, facilitating access to a wider customer base.Cyagen's strategy for future growth hinges on the development of new products and expansion into new markets. The company plans to launch innovative genetically engineered models tailored for specific therapeutic areas by the end of 2022. Additionally, Cyagen aims to expand its presence in European and Asian markets, targeting significant growth in these regions by 2025.
Who invested in Cyagen US
5 investors across 2 rounds
See all investors in Cyagen US
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cyagen US
Who invested in Cyagen US?
Cyagen US has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cyagen US raised?
Cyagen US has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cyagen US last raise money?
Cyagen US's most recent round on record is a Series B, in Feb 2020.
What does Cyagen US do?
Cyagen US is a biotechnology company.
Where is Cyagen US headquartered?
Cyagen US is headquartered in Santa Clara, US.
Which VCs invest in companies like Cyagen US?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cyagen US's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cyagen US? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.